Dynamic changes and multiplication rate of white blood cell count may direct the timing of cytoreduction chemotherapy during induction treatment in newly diagnosed acute promyelocytic leukemia with low-intermediate risk.
APL
WBC
cytoreduction chemotherapy
induction treatment
initiation time
low-intermediate risk
multiplication rate
Journal
Molecular and clinical oncology
ISSN: 2049-9450
Titre abrégé: Mol Clin Oncol
Pays: England
ID NLM: 101613422
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
20
12
2020
accepted:
12
03
2021
entrez:
27
4
2021
pubmed:
28
4
2021
medline:
28
4
2021
Statut:
ppublish
Résumé
In order to explore the optimal timing for initiating cytoreduction chemotherapy following all-trans retinoic acid plus arsenic trioxide administration, 58 newly diagnosed patients with acute promyelocytic leukemia (APL) with low-intermediate mortality risk were retrospectively analyzed. During induction treatment, white blood cell (WBC) count >4x10
Identifiants
pubmed: 33903818
doi: 10.3892/mco.2021.2274
pii: MCO-0-0-02274
pmc: PMC8060852
doi:
Types de publication
Journal Article
Langues
eng
Pagination
112Informations de copyright
Copyright: © Wen et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Blood. 1999 Nov 1;94(9):3015-21
pubmed: 10556184
Am J Clin Oncol. 1982 Dec;5(6):649-55
pubmed: 7165009
Blood. 1993 Dec 1;82(11):3241-9
pubmed: 8241496
Blood. 1997 Aug 1;90(3):1014-21
pubmed: 9242531
Ann Intern Med. 1992 Aug 15;117(4):292-6
pubmed: 1637024
Blood. 2000 Aug 15;96(4):1247-53
pubmed: 10942364
Blood. 2010 Jun 24;115(25):5137-46
pubmed: 20393132
J Natl Compr Canc Netw. 2017 Jul;15(7):926-957
pubmed: 28687581
Biomed Rep. 2018 Sep;9(3):227-232
pubmed: 30271598
N Engl J Med. 2013 Jul 11;369(2):111-21
pubmed: 23841729
Blood. 2019 Apr 11;133(15):1630-1643
pubmed: 30803991
J Clin Oncol. 2003 Dec 15;21(24):4642-9
pubmed: 14673054
Trials. 2018 Sep 5;19(1):476
pubmed: 30185214